Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.510
-0.060 (-3.82%)
Jun 8, 2026, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 168.93 million as of June 8, 2026. Its market cap has increased by 37.17% in one year.
Market Cap
168.93M
Enterprise Value
141.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.51
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 168.93M, an increase of 79.11%. That is a compound annual growth rate of 8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 175.64M | 34.73% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 321.94M |
| Aurora Cannabis | 277.90M |
| Auxly Cannabis Group | 229.37M |
| Organigram Global | 208.14M |
| Cannara Biotech | 165.95M |
| BioSyent | 156.70M |
| Ascend Wellness Holdings | 155.49M |
| Grown Rogue International | 152.46M |